Structure |
Chemical Name |
CAS |
MF |
|
Sitagliptin Defuoro IMpurity 3 |
851307-12-5 |
C15H19F2NO4 |
|
Sitagliptin N-Boc IMpurity |
486460-23-5 |
C21H23F6N5O3 |
|
SulbactaM IMpurity D |
|
|
|
Valsartan N2-Trityl IMpurity |
|
|
|
Vardenafil IMpurity 3 |
1255919-01-7 |
C26H30N6O4S |
|
Montelukast Cyclopropaneacetonitrile |
866923-62-8 |
C35H35ClN2OS |
|
(3R,4R,5R,6S)-2-(acetoxyMethyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate |
461432-24-6 |
C22H27ClO7 |
|
Ezetimibe Impurity |
1510820-22-0 |
C24H23F2NO2 |
|
10,13-bissidechainpaclitaxel |
|
|
|
Istradefylline Impurity A |
|
|
|
(3R,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine dihydrochloride |
|
C14H24Cl2N2 |
|
2-(((3-Methyl-4-nitropyridin-2-yl)Methyl)sulfinyl)-1H- benzo[d]iMidazole |
142384-07-4 |
C14H12N4O3S |
|
Valsartan Desvaleryl Impurity |
676129-92-3 |
C19H21N5O2 |
|
Istradefylline iMpurity |
|
|
|
(E)-Olopatadine Hydrochloride |
949141-22-4 |
C21H24ClNO3 |
|
(3R,4R,5R)-3-(1-Ethylpropoxy)-4-hydroxy-5-[(Methylsulfonyl)oxy]-1-cyclohexene-1-carboxylic Acid Ethyl Ester |
204254-92-2 |
C15H26O7S |
|
(R)-α-[(2,2-DiMethyl-1-oxopropyl)aMino]-4-hydroxybenzeneacetic Acid |
205826-86-4 |
C13H17NO4 |
|
(R)-α-[(2,2-DiMethyl-1-oxopropyl)aMino]-4-hydroxybenzeneacetic Acid |
205826-86-4 |
C13H17NO4 |
|
8-Hydroxy Pitavastatin |
224320-09-6 |
C25H24FNO5 |
|
α-Decitabine |
22432-95-7 |
C8H12N4O4 |
|
Aloin Peracetate |
64951-96-8 |
C37H38O17 |
|
L-Alanine, N-[(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-, 1-Methylethyl ester |
1256490-52-4 |
C18H17F5NO5P |
|
Cefditoren iMpurity 2, Cefditoren open ring |
|
|
|
Ceftriaxone IMpurity C |
|
|
|
Etoricoxib iMpurity 2 |
|
|
|
Lorcaserin iMpurity D |
1030624-36-2 |
C11H14ClNO2 |
|
tert-butyl 4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate |
1651214-74-2 |
C29H37N7O4 |
|
Prasugrel Impurity 4 HCl |
1618107-96-2 |
C20H22Cl2FNO3S |
|
Tofacitinib Impurity K |
|
|
|
N-(3-chloro-4-fluorophenyl)-7 -methoxy-6-(3-morpholinopropoxy)-N-(3-morpholinopropyl)quinazolin-4-amine |
1502829-45-9 |
C29H37ClFN5O4 |
|
5-(hydroxymethyl)-1,2-dihydro-1,2,4-triazol-3-one |
24021-90-7 |
C3H5N3O2 |
|
( 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}acetic acid tert-butylester ) |
475084-96-9 |
C29H37N3O3 |
|
N-(4-Hydroxymethylbenzyl) Cyclam |
176252-20-3 |
C18H32N4O |
|
Alvimopan Impurity 3 |
|
|
|
Nicergoline Impurity G |
|
|
|
Isavuconazole Impurity 1 |
2069200-13-9 |
C13H12F2N4O |
|
Sofosbuvir Impurity23 |
|
|
|
Tacrolimus Impurity 1 |
|
|
|
Bisoprolol EP Impurity F |
1798418-82-2 |
C18H31NO4 |
|
Pantoprazole EP Impurity F |
721924-06-7 |
C17H17F2N3O4S |
|
Rosuvastatin EP Impurity E |
|
|
|
Tiotropium EP Impurity C |
136310-95-7 |
C19H22BrNO3S2 |
|
Eliglustat intermediate 4 |
491833-27-3 |
C23H30N2O4 |
|
2-[(4-Acetylphenyl)methyl]cyclopentan-1-one |
96824-28-1 |
C14H16O2 |
|
Dapoxetine Impurity 1 |
119357-22-1 |
C22H25NO |
|
Mirabegron Impurity 5 |
|
|
|
Milrinone Impurity 5 |
|
|
|
Solifenacin Related Compound 20 |
1300713-32-9 |
C17H17NO |
|
Cefuroxime Impurity 2 |
|
C16H16N4O8S |
|
Cefoxitin Impurity 1 |
|
|
|
Cefazolin Impurity 1 |
|
|
|
Umeclidinium Bromide Impurity 8 |
869113-10-0 |
C27H30BrNO |
|
Nifuratel impurity E |
|
|
|
Valsartan Impurity 14 |
|
C24H29N5O3 |
|
Istradefylline Impurity 4 |
|
|
|
Zolmitriptan Impurity 2 |
|
|
|
Atazanavir Impurity 6 |
1006868-81-0 |
C32H42N4O5 |
|
Palbociclib Impurity 9 |
2204368-66-9 |
C24H29N7O2 |
|
Solifenacin Impurity 1 |
1353274-25-5 |
C19H21NO2 |
|
Vildagliptin Methyl Ester |
|
|
|
Flucloxacillin Impurity B |
|
|
|
Ropinirole impurity |
|
|
|
Mupirocin iMpurity B |
|
C26H44O9 |
|
Nicorandil Impurity 2 |
|
|
|
Piperacillin Impurity 7 |
|
|
|
Defluoro Paroxetine Hydrochloride |
1394842-91-1 |
|
|
Afatinib Impurity 15 |
|
|
|
Milnacipran Impurity 11 |
1410831-12-7 |
C11H10O2 |
|
Mirabegron Impurity 18 |
|
|
|
Atorvastatin lactone |
125995-03-1 |
C33H33FN2O4 |
|
Prucalopride Impurity F |
1900715-98-1 |
C18H26ClN3O4 |
|
tert-butyl (R)-3-(hydroxymethyl)hexanoate |
1928755-17-2 |
C11H22O3 |
|
Alfuzosin |
19216-53-6 |
C12H16N4O2 |
|
Alfuzosin |
19216-53-6 |
C12H16N4O2 |
|
4-[[3-Chloro-4-(2-pyridinylmethoxy)phenyl]amino]-7-ethoxy-6-[(1-methyl-2-pyrrolidinylidene)amino]-3-quinolinecarbonitrile |
1144516-21-1 |
C29H27ClN6O2 |
|
Sofosbuvir Impurity 5 |
|
|
|
ethyl (S)-2-(2-oxopyrrolidin-1-yl)butanoate |
1862335-58-7 |
C9H16ClNO3 |
|
vildagliptin Impurity R |
1803168-09-3 |
C7H8Cl2N2O |
|
Cefmetazole Lactone |
70993-70-3 |
C13H13N3O5S2 |
|
Canagliflozin Impurity 19 |
|
|
|
Canagliflozin Impurity 24 |
|
|
|
Carfilzomib Impurity 5 |
|
|
|
Dolutegravir Impurity 6 |
1357289-29-2 |
C20H19F2N3O5 |
|
Febuxostat Impurity 22 |
|
|
|
Istradefylline Impurity C |
|
|
|
Everolimus O-Ethyl Impurity |
1704711-12-5 |
C54H85NO14 |
|
(3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-1-methyl-4-phenylpiperidine |
324023-99-6 |
C20H23NO3 |
|
Solifenacin Impurity 4(Solifenacin EP Impurity H) |
732228-02-3 |
C23H26N2O2 |
|
849217-77-2 |
849217-77-2 |
C22H20N2O6 |
|
1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, ethyl ester, (3R,4R)- |
1675248-18-6 |
C18H25N5O3 |
|
Amlodipine iMpurity L |
1821498-25-2 |
C17H19ClN2O5 |
|
(6R,7R)-7-[(2,2-dimethylpropanoyl)amino]-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
2384108-14-7 |
C16H20N4O4S3 |
|
methyl (41R,12R,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate |
58000-63-8 |
C21H26N2O3 |
|
(S)-ethyl 2-(((S)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate |
1392015-05-2 |
C17H15F5NO5P |
|
3-(2-cyclopentylidene-2-phenylacetoxy)-1,1-dimethylpyrrolidin-1-ium bromide |
|
C19H26BrNO2 |
|
Apixaban Impurity 16 |
1619934-76-7 |
C31H37N5O6 |
|
Cephalexin Impurity 3 |
|
C16H17N3O4S |
|
(6R,7R)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-pivalamido-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
1798390-48-3 |
C16H20N4O4S3 |
|
(S)-ethyl 3-((R)-5-oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylate(DD) |
|
|
|
Lincomycin EP Impurity B |
37744-65-3 |
C18H32N2O6S |